Our R01 grant entitled "Dysregulated NFkB Pathway Signaling in Myeloproliferative Neoplasms" has officially been activated!
The lab has received a grant from the MPN Research Foundation focused on identifying approaches to leverage NFkB pathway dysregulation for therapeutic benefit in myeloproliferative neoplasms.
Incoming DBBS student Peter Ronning has joined the lab for a summer rotation. Welcome Peter!
Steve has received a 2-year grant from the Damon Runyon Cancer Research Foundation to continue the lab's work interrogating dysregulated cytokine-signaling networks in myeloproliferative neoplasms.
Clinical Research Coordinator Maggie Allen has joined the team. Welcome Maggie!
Steve's webinar presentation describing the lab's work utilizing mass cytometry to query altered cytokine-signaling networks in myeloproliferative neoplasms can be viewed here.
Our paper identifying NFkB pathway hyperactivation has been published in Leukemia. Check it out here!
Graduate student Taylor Brost has been selected to received a BD Biosciences Cancer Research Grant. The award will support her project entitled "Interrogation of Clonal Evolution in Myeloproliferative Neoplasms Utilizing Patient-Specific Induced Pluripotent Stem Cells". Congrats Taylor!
Our report detailing clinical improvement with JAK2 inhibition in Chuvash polycythemia has been published in NEJM!